Trending

Artios

Merck KGaA signs DNA damage response cancer deal with Artios Pharma

Merck KGaA signs DNA damage response cancer deal with Artios Pharma

Germany’s Merck KGaA has joined with UK-based Artios Pharma in a potential multi-billion dollar deal to investigate novel

X

Merck KGaA signs DNA damage response cancer deal with Artios Pharma

https://pharmaphorum.com/news/merck-kgaa-signs-dna-damage-response-cancer-deal-with-artios-pharma/

UK’s Artios raises $84m to further DDR drug research

UK’s Artios raises $84m to further DDR drug research

Management team led development of AZ’s PARP drug Lynparza

X

UK’s Artios raises $84m to further DDR drug research

https://pharmaphorum.com/news/uks-artios-raises-84m-to-further-ddr-drug-research/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com